Clinical trials

We test, we share

By providing accessible clinical trial information, we are commited to helping people - medical practitioners, patients, and their families - improve their knowledge of healthcare testing and results.

We publish the results of our clinical trials openly as part of our global transparency policy.

Here you can find information on the registration and results of our clinical trials.

Clinical Trials in Dermatology by Almirall

Ilse, living with Psoriasis

Closer to patients

We want to be always one step ahead in transforming your life. That’s why we develop digital applications for patients who are included in our clinical studies. Using their mobile phone, patients can share their progress with the clinical sites by sending data and receiving interactive content about their disease progression in a convenient and cost-effective way, as well as educational content that allows them to adopt healthy tips.

Almirall transparency policy

Almirall is committed to disclosing clinical trial information in order to comply with the format and timeline requirements of Health Agencies and the International Committee of Medical Journal Editors (ICMJE).

Before starting the study, clinical trials will be registered by means of public registry databases such as ClinicalTrials.gov and CTIS/EudraCT, or any other national registries, as required and published in leading biomedical journals.

A summary of the results, including Plain Language Summaries, will be reported on registries such as ClinicalTrials.gov, the European Clinical Trials Database (EudraCT), and/or the EU CTIS. Procedures will be followed to ensure results are reported in compliance with applicable laws and regulations.

Almirall is also committed to disclosing clinical trial information and sharing clinical trial data with independent researchers, patients, and healthcare professionals to meet internationally accepted scientific and ethical standards.

Any clinical data requests should be accompanied by a research protocol proposal and (1) include a commitment to the future publication of the results, (2) ensure anonymity of patient data and (3) respect Almirall's confidential commercial information. Our "Terms of Use" agreement must be signed before clinical data may be accessed. To facilitate clinical study data sharing according to our Transparency Policy, researchers can submit a request by sending a proposal here.

All requests will be reviewed independently on a case-by-case basis.

Mireia, living with psoriasis

Almirall transparency policy

All requests will be reviewed independently on a case-by-case basis.

Good practices in clinical trials: our standard

We carry out our global clinical trials efficiently and qualitatively according to internationally accepted scientific and ethical standards. Clinical trials are performed in line with authorities’ requirements in the countries where the trials are performed, and in accordance with European Directives and Guidelines, such as the International Conference on Harmonization (ICH) guideline on Good Clinical Practice, and FDA GCP regulations under Title 21 of the Code of Federal Regulations.

Medical advice

Please keep in mind that the information on this website is not intended to replace advice from healthcare professionals. Patients should always seek medical advice before starting or changing their treatment. Healthcare professionals should consult the approved labelling for the patient's country to ensure that they receive the most up-to-date and appropriate information according to local requirements.